Literature DB >> 22181558

Antibody adsorption and orientation on hydrophobic surfaces.

Meredith E Wiseman1, Curtis W Frank.   

Abstract

The orientation of a monoclonal, anti-streptavidin human IgG1 antibody on a model hydrophobic, CH(3)-terminated surface (1-dodecanethiol self-assembled monolayer on gold) was studied by monitoring the mechanical coupling between the adsorbed layer and the surface as well as the binding of molecular probes to the antibodies. In this study, the streptavidin antigen was used as a probe for the Fab portions of the antibody, while bacteria-derived Protein G' was used as a probe for the Fc region. Bovine serum albumin (BSA) acted as a blocking protein. Monolayer coverage occurred around 468 ng/cm(2). Below 100 ng/cm(2), antibodies were found to adsorb flat-on, tightly coupled to the surface and unable to capture their antigen, whereas the Fc region was able to bind Protein G'. At half-monolayer coverage, there was a transition in the mechanism of adsorption to allow for vertically oriented antibodies, as evidenced by the binding of both Protein G' and streptavidin as well as looser mechanical coupling with the surface. Monolayer coverage was characterized by a reduced level in probe binding per antibody and an even less rigid coupling to the surface.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22181558     DOI: 10.1021/la203095p

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  23 in total

1.  How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.

Authors:  Daniel Serrano; Rachel L Manthe; Eden Paul; Rishi Chadha; Silvia Muro
Journal:  Biomacromolecules       Date:  2016-09-15       Impact factor: 6.988

Review 2.  Site-selective orientated immobilization of antibodies and conjugates for immunodiagnostics development.

Authors:  Min Shen; Chandra K Dixit; James Rusling
Journal:  Methods       Date:  2016-11-19       Impact factor: 3.608

3.  Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.

Authors:  Joshua Kim; Sauradeep Sinha; Melani Solomon; Edgar Perez-Herrero; Janet Hsu; Zois Tsinas; Silvia Muro
Journal:  Biomaterials       Date:  2017-09-06       Impact factor: 12.479

Review 4.  Protein adsorption onto nanomaterials for the development of biosensors and analytical devices: a review.

Authors:  Samir A Bhakta; Elizabeth Evans; Tomás E Benavidez; Carlos D Garcia
Journal:  Anal Chim Acta       Date:  2014-10-29       Impact factor: 6.558

5.  Surfaces Affect Screening Reliability in Formulation Development of Biologics.

Authors:  Mitja Zidar; Gregor Posnjak; Igor Muševič; Miha Ravnik; Drago Kuzman
Journal:  Pharm Res       Date:  2020-01-06       Impact factor: 4.200

6.  Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme.

Authors:  Rachel L Manthe; Maximilian Loeck; Tridib Bhowmick; Melani Solomon; Silvia Muro
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

7.  Orientation-Controlled Bioconjugation of Antibodies to Silver Nanoparticles.

Authors:  Nicole E Pollok; Charlie Rabin; Leilani Smith; Richard M Crooks
Journal:  Bioconjug Chem       Date:  2019-11-15       Impact factor: 4.774

Review 8.  Immunosensor-based label-free and multiplex detection of influenza viruses: State of the art.

Authors:  Hanyuan Zhang; Benjamin L Miller
Journal:  Biosens Bioelectron       Date:  2019-06-25       Impact factor: 10.618

9.  CD133 antibody conjugation to decellularized human heart valves intended for circulating cell capture.

Authors:  John D Vossler; Young Min Ju; J Koudy Williams; Steven Goldstein; James Hamlin; Sang Jin Lee; James J Yoo; Anthony Atala
Journal:  Biomed Mater       Date:  2015-09-03       Impact factor: 3.715

10.  Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.

Authors:  Rasa Ghaffarian; Edgar Pérez Herrero; Hyuntaek Oh; Srinivasa R Raghavan; Silvia Muro
Journal:  Adv Funct Mater       Date:  2016-04-23       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.